Detalhe da pesquisa
1.
Role of serum concentration of VEGFR1 and TIMP2 on clinical outcome in primary cervical cancer: results of a companion protocol of the randomized, NOGGO-AGO phase III adjuvant trial of simultaneous cisplatin-based radiochemotherapy vs. carboplatin and paclitaxel containing sequential radiotherapy.
Cytokine
; 61(3): 755-8, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23415672